, Regulation (EU) 2016/161

In forcesince 2 Oct 2015

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [OJ L 311, 28.11.2001, p. 67.], and in particular Article 54a(2) thereof,

Whereas: